The eftreet of Rbesartan on the serum cysteine-C level in patients with diabetic nephropathy
Xia Xiao
Abstract
Xia Xiao
Abstract
Objective To explore the effect of rbesartan on the serum Cysteine C(CysC)level in patients with diabetic nephropathy.Methods A prospective case-control study of patients with diabetic nephropathy who were ulldel-well glyeemie control,comparing those who had received 24 weeks of Rbesartan(N=40)to those without Rbesartan (N=40).Comparisons were made by measuring the changes of the eysteine-C level serum.Results Rbesartan treated patients had significantly depressed CysC level(P0.01),while the changes in CysC level of the control group had no statistical difference.Conclusion Rbesartan could lower the serum CysteineC(CysC)level in patients with diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the effect of rbesartan on the serum Cysteine C(CysC)level in patients with diabetic nephropathy.Methods A prospective case-control study of patients with diabetic nephropathy who were ulldel-well glyeemie control,comparing those who had received 24 weeks of Rbesartan(N=40)to those without Rbesartan (N=40).Comparisons were made by measuring the changes of the eysteine-C level serum.Results Rbesartan treated patients had significantly depressed CysC level(P0.01),while the changes in CysC level of the control group had no statistical difference.Conclusion Rbesartan could lower the serum CysteineC(CysC)level in patients with diabetic nephropathy.
Key concepts: Medicine, Diabetic nephropathy, Nephropathy, Internal medicine, Gastroenterology, Diabetes mellitus, Endocrinology, Urology